SecBot SecBot
8-K ·Filed Jul 28, 2026

QTI

QT IMAGING HOLDINGS, INC.
NEUTRAL
Impact 2/10
Horizonmonths Processed3mo ago SEC0001628280-26-050189
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

This is a routine annual meeting filing with no new operational or financial disclosures. Monitor the next 10-Q for the actual share count impact from the equity plan amendment and any resulting dilution.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
QTI ▼ -13.10% at T+60d
NEUTRAL call -13.10% · α vs SPY -17.83% · entry $2.71 → $2.36
Entry = T+0 close
Jul 28, 2026
via day close
T+1d
-0.37%
call -0.37% · α -2.05%
$2.70
settled 3mo ago
T+5d
+1.11%
call +1.11% · α -4.42%
$2.74
settled 3mo ago
T+20d
+16.97%
call +16.97% · α +11.95%
$3.17
settled 2mo ago
T+60d
-13.10%
call -13.10% · α -17.83%
$2.36
settled 6d ago

Price Chart

Loading chart...

Executive Summary

QT Imaging Holdings filed an 8-K reporting the results of its 2026 Annual Meeting. Stockholders re-elected two Class II directors, ratified BPM LLP as the independent auditor, and approved an amendment to the 2024 Equity Incentive Plan to increase the number of shares authorized for issuance. This is a routine governance filing with no material financial impact or new business developments.

Key Facts

  • Stockholders re-elected Professor Zeev Weiner and Bryan Timm as Class II directors.
  • Stockholders ratified BPM LLP as the independent registered public accounting firm for FY2026.
  • Stockholders approved an amendment to the 2024 Equity Incentive Plan to increase the number of shares authorized and reserved for issuance.
  • The annual meeting was held on July 28, 2026, with 8,698,769 shares represented out of 13,768,903 outstanding shares.

Financial Impact

No financial figures reported. The equity plan amendment increases share authorization but the specific number of additional shares was not disclosed.

dilution

Risk Factors

  • Potential future dilution from increased share authorization under the 2024 Equity Incentive Plan.
  • No other material risks identified in this filing.

Market Snapshot

Exchange
OTC
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
83% bullish (6 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-050189
Document: a2026x07x28ex991pressrelea.htm0001628280-26-050189
Document: 0001628280-26-050189-index-headers.html0001628280-26-050189
Document: 0001628280-26-050189-index.html0001628280-26-050189
Document: 0001628280-26-050189.txt0001628280-26-050189
4 reports for QTI
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for QTI — sortable, filterable
TypeNow
Aug 31, 2026
8w ago
8-K
NEUTRAL ★ 2/10
$2.77 $2.55▼ −8.12%▼ −8.44%$2.31 (−16.61%)
Aug 18, 2026
10w ago
8-K
BULLISH ★ 6/10
$2.91 $2.69▼ −7.56%▼ −6.57%$2.31 (−20.62%)
Jul 28, 2026
12w ago
8-K
NEUTRAL ★ 2/10
$2.71 $3.17▲ +16.97%▲ +11.95%$2.31 (−14.76%)
Feb 25, 2026
34w ago
8-K
BULLISH ★ 7/10
$5.50 $6.30▲ +14.55%▲ +20.96%$2.31 (−58.00%)
Showing 4 of 4

US Market Status

Market Open — Closes in 6h 2m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 28, 2026